Literature DB >> 1731731

The long-term effects of visible light on the eye.

H R Taylor1, S West, B Muñoz, F S Rosenthal, S B Bressler, N M Bressler.   

Abstract

The relationship between exposure to sunlight and senile cataract, age-related macular degeneration, pterygium, and climatic droplet keratopathy was examined in 838 watermen who work on the Chesapeake Bay. The presence and severity of lenticular, corneal, and macular changes were assessed by either clinical examination or from stereo macular photographs. From detailed exposure histories, ocular exposure was estimated for three bands of visible radiation-violet (400 to 450 nm), blue (400 to 500 nm), or all visible (400 to 700 nm)-as well as for UV-A (320 to 340 nm) and UV-B (290 to 320 nm). The results with each band of visible radiation were similar. Neither cortical nor nuclear cataract was associated with ocular exposure to blue or all visible radiation, but pterygium and climatic droplet keratopathy were more common with higher exposures. Compared with age-matched controls, patients with advanced age-related macular degeneration (geographic atrophy or disciform scarring) had significantly higher exposure to blue or visible light over the preceding 20 years (odds ratio, 1.36 [1.00 to 1.85]) but were not different in respect to exposure to UV-A or UV-B. These data suggest that high levels of exposure to blue or visible light may cause ocular damage, especially later in life, and may be related to the development of age-related macular degeneration.

Entities:  

Mesh:

Year:  1992        PMID: 1731731     DOI: 10.1001/archopht.1992.01080130101035

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  115 in total

1.  Staying safe during the eclipse. Turn your back on the sun.

Authors:  J Dowler
Journal:  BMJ       Date:  1999-08-07

2.  Quantification of the ultraviolet radiation (UVR) field in the human eye in vivo using novel instrumentation and the potential benefits of UVR blocking hydrogel contact lens.

Authors:  J E Walsh; J P Bergmanson; D Wallace; G Saldana; H Dempsey; H McEvoy; L M Collum
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

3.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

4.  Light-induced phosphorylation of crystallins in the retinal pigment epithelium.

Authors:  Hyunju Lee; Hyewon Chung; Sung Haeng Lee; Wan Jin Jahng
Journal:  Int J Biol Macromol       Date:  2010-11-19       Impact factor: 6.953

5.  Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3.

Authors: 
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

6.  How much blue light should an IOL transmit?

Authors:  M A Mainster; J R Sparrow
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

7.  Sutureless amniotic membrane transplantation combined with narrow-strip conjunctival autograft for pterygium.

Authors:  Hande Taylan Sekeroglu; Elif Erdem; Nese Cetin Dogan; Meltem Yagmur; Reha Ersoz; Ahmet Dogan
Journal:  Int Ophthalmol       Date:  2011-12-07       Impact factor: 2.031

Review 8.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

9.  New approach for pterygium removal using 20 % ethanol.

Authors:  Erez Tsumi; Jaime Levy; Anry Pitchkhadze; Amjad Baidousi; Tova Lifshitz
Journal:  Int Ophthalmol       Date:  2012-06-21       Impact factor: 2.031

10.  A model of spectral filtering to reduce photochemical damage in age-related macular degeneration.

Authors:  Sanford M Meyers; Mikhail A Ostrovsky; Robert F Bonner
Journal:  Trans Am Ophthalmol Soc       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.